Natco Pharma share news, announcements and annual reports
NSE: NATCOPHARMBSE: 524816Pharmaceuticals & BiotechnologySmall Cap
Natco Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Dec 1995 on NSE
Last close ₹782.40down ₹5.15 (0.65%)BSE ₹782.50
Share price at the NSE close on 30 Oct 2026. Previous close ₹787.55.
30 Oct: open ₹792.05, high ₹800.90, low ₹779.50
52-week range of traded prices to 30 Oct 2026
₹773.60Low, 22 Oct 2026₹1,226.80High, 12 May 2026
- Next results date: the board meets on 13 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,348 Cr380th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.58%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.08
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,21,54744.0% delivered
Natco Pharma share news and announcements
1,035 announcements, routine notices left out, newest first. Page 16 of 21.
Feb 2013
13 Feb · Dividend
Board of Directors of the Company at their meeting held on February 13, 2013 the Board has recommended payment of an interim dividend of Rs. 4/- per equity share of Rs. 10/- each for the year 2012-2013.
Jan 2013
31 Jan · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended December 31, 2012, to consider Interim Dividend, if any, for the financial year 2012-13 and related matters etc.24 Jan · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in Natco Pharma Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Natco Pharma Limited has vide its letter inter-alia stated, "We have also noted the recent increase in the volume of our share trading but we do not have any information as to the reasons thereof."
Dec 2012
Nov 2012
9 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 08, 2012, has allotted 2,25,122 equity shares of Rs. 10/- each to the eligible employees under ESOP. Further the Company has informed that the Company has acquired, during the quarter, 51% of the paid-up equity capital of NATCO Organics Ltd.
Oct 2012
29 Oct · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended September 30, 2012 and related matters etc.
Sep 2012
20 Sep · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2012. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2012
25 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 26, 2012 to September 29, 2012 (both days inclusive) for the purpose of Annual General Meeting of the Company. The Annual General Meeting of the Company will be held on September 29, 2012.11 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 11, 2012 had authorised Mr. V. C. Nannpaneni, Chairman and Managing Director to fix up the date, time and Venue of the Annual General Meeting as also Book Closure Dates.
Jul 2012
31 Jul · Board meeting
To consider among other things, the unaudited financial Results for the quarter ended June 30, 2012, convening of Annual General Meeting and related matters etc.
Jun 2012
May 2012
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2012, inter alia, has transacted the following : Based on the recommendations of the Remuneration Committee of the Board of Directors, the Board, subject to the approval of members at the ensuing General Meeting, had revised the remuneration payable to Shri V. C. Nannapaneni, Chairman and Managing Director of the Company and redesignated Mr. Rajeev Nannapaneni as Vice Chairman & CEO besides increasing his remuneration w.e.f. June 01, 2012 for a period of three years.16 May · Board meeting
To consider among other things, approval of the Audited Results for the quarter ending March, 2012 along with Audited Annual Accounts for the year 2011-2012 and related matters.9 May · Management
EXIM Bank of India has withdrawn its Nominee Shri C.P. Ravindranath and appointed Shri. T V Rao as its Nominee Director on the Board.3 May · Results
Company will be considering the Audited Results for the quarter and year ending March 31, 2012 instead of Un-audited Results and will be announced on or before May 30, 2012.
Apr 2012
17 Apr · Business
Mar 2012
Feb 2012
28 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2011 A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Feb · Board meeting
Board of Directors at their meeting held on February 09, 2012 have inducted Mr. Nitin Deshmukh as an Additional Director of the Company, who has been nominated by Kotak India Venture Fund I.9 Feb · Corporate action
Date for taking a record of its shareholders eligible for the purpose of payment of Interim Dividend i.e. record date is fixed as February 23, 2012. The said interim dividend pay-by-date is March 01, 2012.9 Feb · Dividend
Board of Directors of the Company at its meeting held on February 09, 2012, inter alia, has declared payment of an interim dividend of Rs. 3/- per equity share of Rs. 10/- each for the year 2011-2012.
Jan 2012
30 Jan · Board meeting
To consider among other things, the unaudited financial Results for the Quarter ended December 31, 2011, to consider Interim Dividend , if any, for the financial year 2011-2012 and related matters etc.
Dec 2011
Nov 2011
28 Nov · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30,2011. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.